BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33601064)

  • 1. Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis.
    Gao Y; Liu H; Tang F; Zhang X; Li F; Ye Q; Yuan H; Lv H; Han T
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101649. PubMed ID: 33601064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.
    Loffredo L; Pastori D; Farcomeni A; Violi F
    Gastroenterology; 2017 Aug; 153(2):480-487.e1. PubMed ID: 28479379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
    Pettinari I; Vukotic R; Stefanescu H; Pecorelli A; Morelli M; Grigoras C; Sparchez Z; Andreone P; Piscaglia F;
    Am J Gastroenterol; 2019 Feb; 114(2):258-266. PubMed ID: 30538290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.
    Wang L; Guo X; Xu X; De Stefano V; Plessier A; Noronha Ferreira C; Qi X
    Adv Ther; 2021 Jan; 38(1):495-520. PubMed ID: 33155180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
    La Mura V; Braham S; Tosetti G; Branchi F; Bitto N; Moia M; Fracanzani AL; Colombo M; Tripodi A; Primignani M
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1146-1152.e4. PubMed ID: 29066371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative Anticoagulants in Preventing Portal Vein Thrombosis in Patients Undergoing Splenectomy Because of Liver Cirrhosis: A Meta-Analysis.
    Zhang JY; Wang YB; Gong JP; Zhang F; Zhao Y
    Am Surg; 2016 Dec; 82(12):1169-1177. PubMed ID: 28234180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis.
    Amitrano L; Guardascione MA; Menchise A; Martino R; Scaglione M; Giovine S; Romano L; Balzano A
    J Clin Gastroenterol; 2010 Jul; 44(6):448-51. PubMed ID: 19730112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies.
    Qi X; De Stefano V; Li H; Dai J; Guo X; Fan D
    Eur J Intern Med; 2015 Jan; 26(1):23-9. PubMed ID: 25566699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
    Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
    BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture.
    Gîrleanu I; Trifan A; Stanciu C; Sfarti C
    World J Gastroenterol; 2018 Oct; 24(39):4419-4427. PubMed ID: 30356984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation treatment of portal vein thrombosis in a patient with cirrhosis awaiting liver transplantation: A case report.
    Wang J; Chai JS; Zhang YM
    Medicine (Baltimore); 2018 Jun; 97(26):e11183. PubMed ID: 29952969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis.
    Ai MH; Dong WG; Tan XP; Xu L; Xu C; Zhang Q; Zhang Y; Li J
    Eur J Gastroenterol Hepatol; 2020 Oct; 32(10):1395-1400. PubMed ID: 32675774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.
    Delgado MG; Seijo S; Yepes I; Achécar L; Catalina MV; García-Criado A; Abraldes JG; de la Peña J; Bañares R; Albillos A; Bosch J; García-Pagán JC
    Clin Gastroenterol Hepatol; 2012 Jul; 10(7):776-83. PubMed ID: 22289875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis.
    Xu X; Guo X; De Stefano V; Silva-Junior G; Goyal H; Bai Z; Zhao Q; Qi X
    Hepatol Int; 2019 Jul; 13(4):468-481. PubMed ID: 31175581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal vein thrombosis: yes or no on anticoagulation therapy.
    Turon F; Hernández-Gea V; García-Pagán JC
    Curr Opin Organ Transplant; 2018 Apr; 23(2):250-256. PubMed ID: 29432256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis.
    Chung JW; Kim GH; Lee JH; Ok KS; Jang ES; Jeong SH; Kim JW
    Clin Mol Hepatol; 2014 Dec; 20(4):384-91. PubMed ID: 25548745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.
    Guerrero A; Campo LD; Piscaglia F; Scheiner B; Han G; Violi F; Ferreira CN; Téllez L; Reiberger T; Basili S; Zamora J; Albillos A;
    J Hepatol; 2023 Jul; 79(1):69-78. PubMed ID: 36858157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.